Skip to main content

Peer Review reports

From: Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase

Original Submission
19 Apr 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Resubmission - Version 6
Submitted Manuscript version 6
Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
26 Feb 2015 Editorially accepted
17 Mar 2015 Article published 10.1186/s12885-015-1137-9

You can find further information about peer review here.

Back to article page